Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.48 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.35 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.34 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3121300 | 1.00 | TSHR (0.58) | TSHRALDH1A1DNM1ABCC4MAPT | |
| SCHEMBL28334887 | 1.00 | TSHR (0.58) | TSHRALDH1A1DNM1ABCC4MAPT | |
| SCHEMBL3109511 | 1.00 | TSHR (0.58) | TSHRALDH1A1DNM1ABCC4MAPT | |
| SCHEMBL3116213 | 1.00 | TSHR (0.58) | TSHRALDH1A1DNM1ABCC4MAPT | |
| SCHEMBL3123219 | 1.00 | TSHR (0.58) | TSHRALDH1A1DNM1ABCC4MAPT | |
| SCHEMBL3119072 | 1.00 | TSHR (0.58) | TSHRALDH1A1DNM1ABCC4MAPT | |
| Bromide SCHEMBL30719251 | 0.97 | TSHR (0.55) | TSHRALDH1A1DNM1ABCC4MAPT | |
| Hydrochloric Acid SCHEMBL27899373 | 0.97 | TSHR (0.55) | TSHRALDH1A1DNM1ABCC4MAPT | |
| SCHEMBL2887665 | 0.97 | — | — | |
| SCHEMBL28011907 | 0.93 | ALDH1A1 (0.50) | TSHRALDH1A1DNM1ABCC4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3539993-A1 | CYCLOPROPYL SUBSTITUTED METALLOCENE CATALYSTS | ExxonMobil Chemical Patents Inc. (US) | 2019-09-18 | — | — | EP | disclosed |
| EP-3022233-B1 | CYCLOPROPYL SUBSTITUTED METALLOCENE CATALYSTS | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2019-05-01 | — | — | EP | disclosed |
| EP-2240520-B1 | PRODUCTION OF PROPYLENE-BASED POLYMERS | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2019-04-24 | — | — | EP | disclosed |
| EP-3022234-B1 | SUBSTITUTED METALLOCENE CATALYSTS | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2018-12-26 | — | — | EP | disclosed |
| US-9938364-B2 | Substituted metallocene catalysts | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2018-04-10 | — | — | US | disclosed |
| US-20180066083-A1 | Cyclopropyl Substituted Metallocene Catalysts | EXXONMOBIL CHEMICAL PATENTS INC. | 2018-03-08 | — | — | US | disclosed |
| US-9834628-B2 | Cyclopropyl substituted metallocene catalysts | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-12-05 | — | — | US | disclosed |
| US-20170015767-A1 | Substituted Metallocene Catalysts | EXXONMOBIL CHEMICAL PATENTS INC. | 2017-01-19 | — | — | US | disclosed |
| US-9458254-B2 | Substituted metallocene catalysts | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2016-10-04 | — | — | US | disclosed |
| EP-1960411-B1 | HALOGEN SUBSTITUTED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION | EXXONMOBIL CHEM PATENTS INC (US) | 2016-08-31 | — | — | EP | disclosed |
| WO-2005095469-A1 | CATALYST COMPOSITION AND USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2005-10-13 | — | — | WO | disclosed |
| US-20050209420-A1 | Catalyst composition and use thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-09-22 | — | — | US | disclosed |
| CN-1219800-C | Polar group-containing olefin copolymer, thermoplastic resin composition containing the same, and use thereof | MITSUI CHEMICALS INC (JP) | 2005-09-21 | — | — | CN | disclosed |
| EP-1521758-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2005-04-13 | — | — | EP | disclosed |
| US-20040242814-A1 | COPOLYMERS OF ETHYLENE AND/OR ALPHA-OLEFINS AND VICINALLY DISUBSTITUTED OLEFINS | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-12-02 | — | — | US | disclosed |
| US-20040122192-A1 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof | MITSUI CHEMICALS, INC. | 2004-06-24 | — | — | US | disclosed |
| WO-2004007509-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-01-22 | — | — | WO | disclosed |
| US-20020156207-A1 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2002-10-24 | — | — | US | disclosed |
| CN-1342715-A | Polar group-containing olefin copolymer, process for producing the same, thermoplastic resin composition containing the same, and use thereof | MITSUI CHEMICALS INC (JP) | 2002-04-03 | — | — | CN | disclosed |
| EP-1186619-A2 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition contaning the copolymer, and uses thereof | Mitsui Chemicals, Inc. (JP) | 2002-03-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050209420-A1 | Catalyst composition and use thereof | DGAT1, DGAT2, ALOX5 | TSHR 4852/4885ALDH1A1 2505/4885DNM1 45/4885 |
| US-20180066083-A1 | Cyclopropyl Substituted Metallocene Catalysts | CPNE4, TIMM13, NECTIN4 | TSHR 4546/4885ALDH1A1 767/4885DNM1 368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.